Brain tumor samples used to tailor drug cocktails in recurrent glioma trial
NCT ID NCT05532397
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests a new way to choose drug combinations for people with recurrent high-grade astrocytic glioma, a type of aggressive brain cancer. Researchers take a sample of the tumor, grow it in the lab, and test many drug combinations to find the best one for that patient. The goal is to see if this personalized approach can improve how long patients live without the cancer growing. Only 10 participants will be enrolled in this early-stage trial.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
personalized drug combinations selected via QPOP platform
What this could lead to
If successful, this approach could help doctors choose more effective drug combinations for individual patients with recurrent brain cancer, potentially improving survival.
What could go wrong
This is a very early, small study (10 participants) testing a new method. The personalized combinations may not work better than standard treatments, and the platform may not be feasible for all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA, ASTROCYTIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Hematology-Oncology, National University Hospital
RECRUITINGSingapore, 119074, Singapore
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Ng Teng Fong General Hospital
NOT_YET_RECRUITINGSingapore, 609606, Singapore
Contact Phone: •••-•••-••••
Contact